The Osteoarticular Manifestations in Patients With Gitelman Syndrome
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 120
- Locations
- 1
- Primary Endpoint
- The presence of chondrocalcinosis
Study Overview
Brief Summary
Patients with clinically and genetically confirmed Gitelman Syndrome are screened for CPPD, and the clinical and radiographic manifestations are collected and analyzed.
Detailed Description
Patients with clinically and genetically confirmed Gitelman Syndrome are screened for calcium pyrophosphate deposition, and the clinical data and radiographic manifestations are collected and analyzed to investigate the osteoarticular features in patients with Gitelman Syndrome.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients confirmed with Gitelman Syndrome
Exclusion Criteria
- •Patients with other confounding situations such as Bartter Syndrome, hyperparathyroidism
Outcomes
Primary Outcomes
The presence of chondrocalcinosis
Time Frame: From the enrollment to the performance of the CPPD screen
The presence of chondrocalcinosis on conventional radiograph or computed tomography in patients with Gitelman Syndrome
Secondary Outcomes
No secondary outcomes reported
